Cancer BiologyResearchPeer-reviewed
Novel combination of irreversible electroporation and allogenic chimeric antigen receptor (CAR) T-cell therapy synergizes therapeutic outcomes in a preclinical human pancreatic cancer mouse model
Edward J. Jacobs, Julio P. Arroyo, Sam Salamizadeh Parizi…·Rafael V. Davalos
This study combines irreversible electroporation with CAR T-cell therapy to improve outcomes in a pancreatic cancer mouse model by targeting residual tumor cells post-ablation.
4 citationstop 1%